Microcrystallization for active ingredients
- proprietary technological platform for continuous crystallization processes for the manufacture of pure and highly crystalline API-particles. The particle can be adapted to the requirements of the product. Accessible size range from around 500 nm to 50 µm.
- the high precision and reproducibility in the designed particle size, the narrow particle size distribution and the high crystallinity make our microcrystalline products a better alternative when compared to the conventional technologies, especially in the case of
- pulmonary applications
- low and ultra low dose forms
- APIs with low bioavailability and with problems in micronisation with conventional technologies